Biotech Industry News

A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

technical.ly - Michaela Althouse - Virongy Biosciences is adding 70 new jobs in biotech
Virongy Biosciences is adding 70 new jobs in biotech
Technical.ly

Virongy Biosciences, a biotech company developing virus-based tech out of Manassas, Virginia, just got some support from state government entities to make a huge expansion to its team. Virginia Governor Glenn Youngkin, the Prince William County…

ctinsider.com - Luther Turmelle - Irish biotech firm to locate North American headquarters in New Haven area
Irish biotech firm to locate North American headquarters in New Haven area
CT Insider

An Irish biotech company with some high profile investors is coming to the New Haven area to set up its North American headquarters by the end of the year. Nuritas, whose investors include rock musicians Bono and The Edge from the band U2, plans to…

siliconrepublic.com - Blathnaid O'Dea - Irish biotech Nuritas to build US HQ as CEO relocates to Connecticut
Irish biotech Nuritas to build US HQ as CEO relocates to Connecticut
Silicon Republic

Dr Nora Khaldi, CEO of Nuritas, will lead the company's expansion from the US. The expansion to North America was announced last year following its $45m Series B raise. Dublin-based biotech company Nuritas is expanding into the US by building a new…

endpts.com - Paul Schloesser - Genomics biotech undergoes a facelift, rebranding from Clover to Character Biosciences
Genomics biotech undergoes a facelift, rebranding from Clover to Character Biosciences
Endpoints News

Cheng Zhang, CEO of Character Biosciences (Character) Though Clover Therapeutics has a new identity, CEO Cheng Zhang is making one thing clear: the genomics outfit's goals and mission remain the same. Simply put, “we're doubling down on…

prweb.com - BioTech company LynxDx welcomes new executive leadership
BioTech company LynxDx welcomes new executive leadership
PRWeb

The company is now poised to advance usage of its ground-breaking prostate cancer detection test, MyProstateScore. LynxDx, an Ann Arbor-based biotech startup and developer of the revolutionary MyProstateScore™ (MPS), announces the addition…

cnbc.com - CNBC.com staff - 32. Biobot Analytics
32. Biobot Analytics
CNBC

Founders: Mariana Matus (CEO), Newsha Ghaeli Headquarters: Cambridge, Massachusetts Key technologies: Artificial intelligence, deep neural networks/deep learning, machine learning Previous appearances on Disruptor 50 List: 0 Amid the pandemic you…

dailymail.co.uk - Huntsville, Ala beats Boulder, Col for best place to live in America
Huntsville, Ala beats Boulder, Col for best place to live in America
Mail Online

Huntsville's housing market put it over the top for best metro area to put down roots, according to U.S. News & World Report. The average home in Alabama's biggest city cost $192,667, compared to the national average of more that $365,000 The…

endpts.com - John Carroll - Presenting a live Endpoints News event: Managing a biotech in turbulent times
Presenting a live Endpoints News event: Managing a biotech in turbulent times
Endpoints News

Biotech is one of the smartest, best ed­u­cat­ed in­dus­tries on the plan­et. PhDs abound. We've had a long enough track record to see a new gen­er­a­tion of savvy, ex­pe­ri­enced ex­ecs…

bostonglobe.com - Ryan Cross - Remix Therapeutics raises $70m to develop drugs that reprogram RNA - The Boston Globe
Remix Therapeutics raises $70m to develop drugs that reprogram RNA - The Boston Globe
BostonGlobe.com

Remix Therapeutics is cashing in on biotech investors' continued interest in RNA. The Cambridge startup has raised 70 million in series B financing to develop drugs that “reprogram RNA processing” to treat cancer and nervous system…

phys.org - Science X staff - Method to cultivate microbial communities in a permanently stable manner
Method to cultivate microbial communities in a permanently stable manner
Phys.org

The capabilities of complex microbial communities are used for numerous biotechnological processes. This requires special compositions of the microbial communities. However, these are often unstable and susceptible to disruption. UFZ researchers…

thehindu.com - Vijaysree Venkatraman - Book Review: Robert Buderi's 'Where Futures Converge' chronicles the transformative Kendall Square
Book Review: Robert Buderi's 'Where Futures Converge' chronicles the transformative Kendall Square
The Hindu

IF your travels take you to Boston, Massachusetts, do take the T—the first subway system in the United States, built in 1897—to get around town and visit Cambridge. Get down at the Kendall/MIT station on the Red Line; yes, this is the…

economist.com - Commercialising Quantum | May 17th - 19th 2022
Commercialising Quantum | May 17th - 19th 2022
The Economist

Minister for science, research and innovation, department for business, energy & industrial strategy, UK Government X Minister for science, research and innovation, department for business, energy & industrial strategy, UK Government May 17th 2022…

etfdailynews.com - $21.79 Million in Sales Expected for Fortress Biotech, Inc. (NASDAQ:FBIO) This Quarter
$21.79 Million in Sales Expected for Fortress Biotech, Inc. (NASDAQ:FBIO) This Quarter
ETF Daily News

Wall Street brokerages expect Fortress Biotech, Inc. (NASDAQ:FBIO – Get Rating) to report $21.79 million in sales for the current quarter, according to Zacks. Five analysts have made estimates for Fortress Biotech's earnings, with estimates…

etfdailynews.com - Fortress Biotech, Inc. (NASDAQ:FBIO) Receives Consensus Recommendation of 'Buy' from Brokerages
Fortress Biotech, Inc. (NASDAQ:FBIO) Receives Consensus Recommendation of 'Buy' from Brokerages
ETF Daily News

Fortress Biotech, Inc. (NASDAQ:FBIO – Get Rating) has received an average recommendation of “Buy” from the eight research firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated…

etfdailynews.com - Head to Head Survey: Nautilus Biotechnology (NAUT) and The Competition
Head to Head Survey: Nautilus Biotechnology (NAUT) and The Competition
ETF Daily News

Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its competitors? We will compare Nautilus Biotechnology to related…

Receive a Daily briefing on Biotech Industry News

Get Started